Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

10.61
Delayed Data
As of 11:34am ET
 -0.01 / -0.09%
Today’s Change
5.70
Today|||52-Week Range
11.34
+73.37%
Year-to-Date
Institutional investors purchased a net $30.4 thousand shares of ORMP during the quarter ended May 2017. This may signal that the smart money is gaining interest in this company as the 1.45% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Individual stakeholders24.44%
Other institutional1.21%
Mutual fund holders0.23%

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Oramed Pharmaceuticals Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Glenmede Investment Management LP0.23%30,000297,90000.00%
Bank of Singapore Ltd.0.23%29,925297,15500.00%
Renaissance Technologies LLC0.19%25,100249,243+25,100--
PNC Bank, NA (Investment Manageme...0.16%21,200210,51600.00%
KCG Americas LLC0.12%16,077159,645+16,077--
IBI Mutual Funds Management (1978...0.11%14,058139,59600.00%
Morgan Stanley Smith Barney LLC (...0.10%12,635125,466-397-3.05%
Wells Fargo Clearing Services LLC0.08%10,450103,769+625+6.36%
ETF Managers Group LLC0.07%8,83887,761+8,838--
Cutler Group LP0.04%4,90448,697-1,200-19.66%

Top 10 Mutual Funds Holding Oramed Pharmaceuticals Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
I.B.I. Foreign Equity Liable0.11%14,058139,59600.00%
BlueStar TA-BIGITech Israel Techn...0.07%9,44293,75900.00%
Fidelity Nasdaq Composite Index F...0.05%6,45464,08800.00%
Janus Obesity ETF (The)0.00%4023,99200.00%
Magic BLUESTAR TECHN 4A KTF0.00%3943,912-41-9.43%